A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers
NCT05040880
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Telmione plus 80/12.5mg
DRUG:
Micardis plus 80/12.5mg
Sponsor
HK inno.N Corporation